| Dr Diana Weedman Molavi, MD | |
|
2401 W Belvedere Ave, Suite 23, Baltimore, MD 21215-5216 | |
| (410) 601-5090 | |
| Not Available |
| Full Name | Dr Diana Weedman Molavi |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 25 Years |
| Location | 2401 W Belvedere Ave, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215987334 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | D63948 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sinai Hospital Of Baltimore | Baltimore, MD | Hospital |
| Umd Shore Medical Center At Easton | Easton, MD | Hospital |
| Northwest Hospital Center | Randallstown, MD | Hospital |
| Carroll Hospital Center | Westminster, MD | Hospital |
| University Of Md Shore Medical Ctr At Chestertown | Chestertown, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chester River Hospital Center | 0749220671 | 18 |
| Hct Pathology Services Llc | 2961509856 | 18 |
| Drs Hicken Cranley Taylor Pa | 5991776387 | 21 |
News Archive
According to new research, Alzheimer's disease may be due to abnormalities in the regions of the brain that operate the "default state", a term used to describe the cognitive state people defer to when musing, daydreaming, or thinking to themselves.
X-BODY BioSciences, a developer of human monoclonal antibody therapeutics, today announced it has been awarded a research grant under the Patient Protection and Affordable Care Act of 2010 for its human monoclonal antibody therapeutic project targeting metastatic tumor stem cells.
Covidien, a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, COV Delaware Corporation, to purchase all of the outstanding shares of common stock of ev3 Inc. The tender offer expired at 12:00 midnight ET, at the end of July 9, 2010, and was not extended.
A $250,000 grant from the Centers for Disease Control and Prevention (CDC) will support a Rhode Island Hospital research study aimed at reducing the state's leading cause of accidental death among adults. Researchers will explore the use and effectiveness of statewide prescription monitoring programs (PMP) in reducing the number of accidental overdose deaths involving prescription opioids like OxyContin and Vicodin in both Rhode Island and Connecticut.
› Verified 2 days ago
| Entity Name | Drs Hicken Cranley Taylor Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154401396 PECOS PAC ID: 5991776387 Enrollment ID: O20040731000367 |
News Archive
According to new research, Alzheimer's disease may be due to abnormalities in the regions of the brain that operate the "default state", a term used to describe the cognitive state people defer to when musing, daydreaming, or thinking to themselves.
X-BODY BioSciences, a developer of human monoclonal antibody therapeutics, today announced it has been awarded a research grant under the Patient Protection and Affordable Care Act of 2010 for its human monoclonal antibody therapeutic project targeting metastatic tumor stem cells.
Covidien, a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, COV Delaware Corporation, to purchase all of the outstanding shares of common stock of ev3 Inc. The tender offer expired at 12:00 midnight ET, at the end of July 9, 2010, and was not extended.
A $250,000 grant from the Centers for Disease Control and Prevention (CDC) will support a Rhode Island Hospital research study aimed at reducing the state's leading cause of accidental death among adults. Researchers will explore the use and effectiveness of statewide prescription monitoring programs (PMP) in reducing the number of accidental overdose deaths involving prescription opioids like OxyContin and Vicodin in both Rhode Island and Connecticut.
› Verified 2 days ago
| Entity Name | Chester River Hospital Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679536809 PECOS PAC ID: 0749220671 Enrollment ID: O20050510000504 |
News Archive
According to new research, Alzheimer's disease may be due to abnormalities in the regions of the brain that operate the "default state", a term used to describe the cognitive state people defer to when musing, daydreaming, or thinking to themselves.
X-BODY BioSciences, a developer of human monoclonal antibody therapeutics, today announced it has been awarded a research grant under the Patient Protection and Affordable Care Act of 2010 for its human monoclonal antibody therapeutic project targeting metastatic tumor stem cells.
Covidien, a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, COV Delaware Corporation, to purchase all of the outstanding shares of common stock of ev3 Inc. The tender offer expired at 12:00 midnight ET, at the end of July 9, 2010, and was not extended.
A $250,000 grant from the Centers for Disease Control and Prevention (CDC) will support a Rhode Island Hospital research study aimed at reducing the state's leading cause of accidental death among adults. Researchers will explore the use and effectiveness of statewide prescription monitoring programs (PMP) in reducing the number of accidental overdose deaths involving prescription opioids like OxyContin and Vicodin in both Rhode Island and Connecticut.
› Verified 2 days ago
| Entity Name | Hct Pathology Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598831976 PECOS PAC ID: 2961509856 Enrollment ID: O20070530000295 |
News Archive
According to new research, Alzheimer's disease may be due to abnormalities in the regions of the brain that operate the "default state", a term used to describe the cognitive state people defer to when musing, daydreaming, or thinking to themselves.
X-BODY BioSciences, a developer of human monoclonal antibody therapeutics, today announced it has been awarded a research grant under the Patient Protection and Affordable Care Act of 2010 for its human monoclonal antibody therapeutic project targeting metastatic tumor stem cells.
Covidien, a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, COV Delaware Corporation, to purchase all of the outstanding shares of common stock of ev3 Inc. The tender offer expired at 12:00 midnight ET, at the end of July 9, 2010, and was not extended.
A $250,000 grant from the Centers for Disease Control and Prevention (CDC) will support a Rhode Island Hospital research study aimed at reducing the state's leading cause of accidental death among adults. Researchers will explore the use and effectiveness of statewide prescription monitoring programs (PMP) in reducing the number of accidental overdose deaths involving prescription opioids like OxyContin and Vicodin in both Rhode Island and Connecticut.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Diana Weedman Molavi, MD 2401 W Belvedere Ave, Suite 23, Baltimore, MD 21215-5216 Ph: (410) 601-5090 | Dr Diana Weedman Molavi, MD 2401 W Belvedere Ave, Suite 23, Baltimore, MD 21215-5216 Ph: (410) 601-5090 |
News Archive
According to new research, Alzheimer's disease may be due to abnormalities in the regions of the brain that operate the "default state", a term used to describe the cognitive state people defer to when musing, daydreaming, or thinking to themselves.
X-BODY BioSciences, a developer of human monoclonal antibody therapeutics, today announced it has been awarded a research grant under the Patient Protection and Affordable Care Act of 2010 for its human monoclonal antibody therapeutic project targeting metastatic tumor stem cells.
Covidien, a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, COV Delaware Corporation, to purchase all of the outstanding shares of common stock of ev3 Inc. The tender offer expired at 12:00 midnight ET, at the end of July 9, 2010, and was not extended.
A $250,000 grant from the Centers for Disease Control and Prevention (CDC) will support a Rhode Island Hospital research study aimed at reducing the state's leading cause of accidental death among adults. Researchers will explore the use and effectiveness of statewide prescription monitoring programs (PMP) in reducing the number of accidental overdose deaths involving prescription opioids like OxyContin and Vicodin in both Rhode Island and Connecticut.
› Verified 2 days ago
Serena Maria Bagnasco, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Baltimore, MD 21224 Phone: 410-955-2660 | |
Dr. Adeboye Oluwaseyi Osunkoya, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 N Broadway, Johns Hopkins Pathology , Weinberg Room 2242, Baltimore, MD 21231 Phone: 405-808-5361 | |
Michael T. O'malley, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2401 W Belvedere Ave, Baltimore, MD 21215 Phone: 410-644-4379 Fax: 410-644-4325 | |
Michael Edward Kallen, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 N Broadway St, Baltimore, MD 21287 Phone: 410-955-3580 Fax: 410-614-1287 | |
Deyin Xing, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 North Broadway, Weinberg 2268, Baltimore, MD 21231 Phone: 410-955-3580 Fax: 410-614-1287 | |
Matthew Grant Gabrielson, Pathology Medicare: Medicare Enrolled Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-3980 | |
Robert A. Palermo, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6701 N Charles St, Baltimore, MD 21204 Phone: 443-849-2257 Fax: 443-849-3016 |